MedPath

UNIVERSITY OF NEW SOUTH WALES

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

219

Active:17
Completed:76

Trial Phases

5 Phases

Phase 1:8
Phase 2:3
Phase 3:12
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (204 trials with phase data)• Click on a phase to view related trials

Not Applicable
172 (84.3%)
Phase 3
12 (5.9%)
Phase 4
9 (4.4%)
Phase 1
8 (3.9%)
Phase 2
3 (1.5%)
No trials found

News

Conflicting Evidence Emerges on Ketamine's Effectiveness for Chronic Pain Management

A Cleveland Clinic study of over 1,000 patients found that low-dose ketamine infusions led to significant improvements in pain, physical function, and sleep for 20-46% of chronic pain patients, with benefits lasting at least six months.

Brain Training Game Shows Promise for Drug-Free Nerve Pain Treatment in First Clinical Trial

Researchers from the University of New South Wales developed PainWaive, an interactive brain training system that teaches patients to alter their brainwaves through neurofeedback games for nerve pain management.

Cuprior Shows Promise in Treating High-Risk Neuroblastoma in Children

A new study suggests that triethylenetetramine (TETA), known as Cuprior, can improve outcomes for children with high-risk neuroblastoma.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.